/Investor DB

Mayo Clinic Ventures — 2026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Open Evidenceopenevidence.comJan 2026

AI company developing a medical search engine used by physicians for clinical decision support.

Daniel Nadler(Founder)inZachary Ziegler(Founder)Daniel Nadler Zachary Ziegler(Founder)Zack Ziegler(Founder)

Co-investorsAlkeon InnovationAmity VenturesAndreessen HorowitzBas1s VenturesBond Capital ManagementBreyer Capital+26 more

Transcripta Biotranscriptabio.comin𝕏Jan 2026

Transcripta Bio develops medicines for patients with serious diseases by mapping how molecules affect human cells at single-cell resolution.

AI & Machine LearningBiotechDeep Tech

Co-investorsBlueYard CapitalJAZZ Venture PartnersARCH Venture PartnersDCVC BioInsight Partners

Views MLviewsml.cominApr 2026

ViewsML applies AI to support the development and delivery of precision medicines, including virtual IHC technology for pathology.

AI & Machine LearningBiotechHealthtechMedical Devices

Kenneth To(Chief Executive Officer)inKeith Jalbert(Chief Commercial Officer)Christopher Jackson(Chief Scientific Officer)inGeorge Hennen(Chief Technology Officer)inRafay Azhar(Medical Director)in

Co-investorsDebiopharm Innovation FundSFU VentureLabsSwan Venture FundWittington VenturesWUTIF Capital

Vitestrovitestro.cominMar 2026

Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.

HealthtechMedical DevicesRoboticsNetherlands, NL

Toon Overbeeke(Co-founder & CEO)inBrian Joseph(Co-founder)in

Co-investorsNYBC VenturesSonder CapitalIntervestInvest-NL

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.